Jonathan Sterne
Jonathan A.C. Sterne is a British statistician, NIHR Senior Investigator, Professor of Medical Statistics and Epidemiology, and the former Head of School of Social and Community Medicine at the University of Bristol.[1] He is co-author of “Essential Medical Statistics”, which received Highly Commended honors in the 2004 BMA Medical Book Competition.[2] WorkSterne has been identified by Clarivate Analytics as the a "Highly Cited Researcher" in each of the last three years, as demonstrated by his production of multiple highly cited papers that rank in the top 1% by citations for field and year in Web of Science.[3] He has a longstanding interest in methodology for systematic reviews and meta-analyses, the clinical epidemiology of HIV and AIDS in the era of antiretroviral therapy, causal inference, methodology for epidemiology and health services research, and epidemiology of asthma and allergic diseases.[1] He has been leading the development of the ROBINS-I tool for assessing risk of bias in non-randomized studies of interventions and the development of the Cochrane Risk of Bias (RoB) tool for randomized trials. He is also leading a large collaboration of HIV cohort studies that has led to advances in our understanding of prognosis of HIV positive people. In addition, he has written a number of meta-analysis software routines used by students and researchers around the world.[4] On 28 August 2019 Sterne, along with Julian Higgins and colleagues, published in The British Medical Journal the RoB 2 tool, an updated version of the most widely used tool for assessing risk of bias in randomized trials included in systematic reviews.[5] EducationSterne completed his undergraduate studies in mathematics at the University of Oxford. He holds an MSc and PhD in statistics from the University College London.[1] References
|